US Preventive Services Task Force recommends against a commonly used prostate cancer screening.
Daily News Roundup
US Preventive Services Task Force recommends against a commonly used prostate cancer screening.
A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.
Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.
The FDA and NIH dispute reports that clinical trial data is being under-reported.
Principal investigators with medical training have a slightly higher NIH funding rate than those with just a PhD.
The newly appointed chief of one Institute gives up his appointment days before starting.
A scientist who claimed to have injected monkey embryonic stem cells into the eyes of rats to improve their vision accepts the penalty for research misconduct.
Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.
A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.